Regulation of SOCS-3 expression by leptin and its co-localization with insulin receptor in rat skeletal muscle cells

Molecular and Cellular Endocrinology

Volumn 267, Issue 1-2, 2007, Pages 38-45

  Eguchi, Megumi ^a   Gillis, Lisa C ^a   Liu, Ying ^a   Lyakhovsky, Natalia ^a   Du, Min ^a   McDermott, John C ^a   Sweeney, Gary ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

Insulin receptor; Leptin; Obesity; SOCS 3

Indexed keywords

GENE PRODUCT; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN RECEPTOR; LEPTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SERINE; SUPPRESSOR OF CYTOKINE SIGNALING 3; THREONINE;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; SKELETAL MUSCLE; SOCS 3 GENE;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOPRECIPITATION; INSULIN; LEPTIN; MICE; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, INSULIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TIME FACTORS;

EID: 33847299599     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.11.009     Document Type: Article

References (42)

1. Ahima R.S., and Flier J.S. Leptin. Annu. Rev. Physiol. 62 (2000) 413-437
2. Auernhammer C.J., Bousquet C., and Melmed S. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 6964-6969
3. Bjorbaek C., Elmquist J.K., Frantz J.D., Shoelson S.E., and Flier J.S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell 1 (1998) 619-625
4. Bjorbaek C., El-Haschimi K., Frantz J.D., and Flier J.S. The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 274 (1999) 30059-30065
5. Cacalano N.A., Sanden D., and Johnston J.A. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras. Nat. Cell Biol. 3 (2001) 460-465
6. Ceddia R.B., and Sweeney G. Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells. J. Physiol. 555 (2004) 409-421
7. Ceddia R.B., Koistinen H.A., Zierath J.R., and Sweeney G. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J. 16 (2002) 1163-1176
8. Cox D.M., Du M., Marback M., Yang E.C., Chan J., Siu K.W., and McDermott J.C. Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A. J. Biol. Chem. 278 (2003) 15297-15303
9. Emanuelli B., Peraldi P., Filloux C., Sawka-Verhelle D., Hilton D., and Van Obberghen E. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J. Biol. Chem. 275 (2000) 15985-15991
10. Emanuelli B., Peraldi P., Filloux C., Chavey C., Freidinger K., Hilton D.J., Hotamisligil G.S., and Van Obberghen E. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J. Biol. Chem. 276 (2001) 47944-47949
11. Emilsson V., Arch J.R., de Groot R.P., Lister C.A., and Cawthorne M.A. Leptin treatment increases suppressors of cytokine signaling in central and peripheral tissues. FEBS Lett. 455 (1999) 170-174
12. Howard J.K., Cave B.J., Oksanen L.J., Tzameli I., Bjorbaek C., and Flier J.S. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat. Med. 10 (2004) 734-738
13. Johnston A.M., Pirola L., and Van Obberghen E. Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling. FEBS Lett. 546 (2003) 32-36
14. Kahn B.B. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 92 (1998) 593-596
15. Kahn B.B., and Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 106 (2000) 473-481
16. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89 (2004) 2548-2556
17. Kile B.T., Schulman B.A., Alexander W.S., Nicola N.A., Martin H.M., and Hilton D.J. The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci. 27 (2002) 235-241
18. Kovanen P.E., and Leonard W.J. Inhibitors keep cytokines in check. Curr. Biol. 9 (1999) R899-R902
19. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S., et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1 (1995) 1155-1161
20. Margetic S., Gazzola C., Pegg G.G., and Hill R.A. Leptin: a review of its peripheral actions and interactions. Int. J. Obes. Relat. Metab. Disord. 26 (2002) 1407-1433
21. Mooney R.A., Senn J., Cameron S., Inamdar N., Boivin L.M., Shang Y., and Furlanetto R.W. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J. Biol. Chem. 276 (2001) 25889-25893
22. Pirola L., Johnston A.M., and Van Obberghen E. Modulators of insulin action and their role in insulin resistance. Int. J. Obes. Relat. Metab. Disord. 27 Suppl. 3 (2003) S61-S64
23. Rajala M.W., and Scherer P.E. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144 (2003) 3765-3773
24. Rieusset J., Bouzakri K., Chevillotte E., Ricard N., Jacquet D., Bastard J.P., Laville M., and Vidal H. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes 53 (2004) 2232-2241
25. Rui L., Yuan M., Frantz D., Shoelson S., and White M.F. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277 (2002) 42394-42398
26. Sadowski C.L., Choi T.S., Le M., Wheeler T.T., Wang L.H., and Sadowski H.B. Insulin induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 skeletal muscle cells is mediated by Stat5*. J. Biol. Chem. 276 (2001) 20703-20710
27. Sato N., Nakayama M., and Arai K. Fluctuation of chromatin unfolding associated with variation in the level of gene expression. Genes Cells 9 (2004) 619-630
28. Senn J.J., Klover P.J., Nowak I.A., Zimmers T.A., Koniaris L.G., Furlanetto R.W., and Mooney R.A. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 278 (2003) 13740-13746
29. Shi H., Tzameli I., Bjorbaek C., and Flier J.S. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J. Biol. Chem. 279 (2004) 34733-34740
30. Spangenburg E.E. SOCS-3 induces myoblast differentiation. J. Biol. Chem. 280 (2005) 10749-10758
31. Spangenburg E.E., Brown D.A., Johnson M.S., and Moore R.L. Exercise increases SOCS-3 expression in skeletal muscle: potential relationship to IL-6 expression. J. Physiol. 572 3 (2006) 839-848
32. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., and Hilton D.J. A family of cytokine-inducible inhibitors of signalling. Nature 387 (1997) 917-921
33. Steinberg G.R., McAinch A.J., Chen M.B., O'Brien P.E., Dixon J.B., Cameron-Smith D., and Kemp B.E. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J. Clin. Endocrinol. Metab. 91 (2006) 3592-3597
34. Steppan C.M., Wang J., Whiteman E.L., Birnbaum M.J., and Lazar M.A. Activation of SOCS-3 by resistin. Mol. Cell Biol. 25 (2005) 1569-1575
35. Sweeney G. Leptin signalling. Cell Signal. 14 (2002) 655-663
36. Sweeney G., Keen J., Somwar R., Konrad D., Garg R., and Klip A. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in I6 rat skeletal muscle cells. Endocrinology 142 (2001) 4806-4812
37. Tajmir P., Kwan J.J., Kessas M., Mozammel S., and Sweeney G. Acute and chronic leptin treatment mediate contrasting effects on signaling, glucose uptake, and GLUT4 translocation in L6-GLUT4myc myotubes. J. Cell Physiol. 197 (2003) 122-130
38. Tajmir P., Ceddia R.B., Li R.K., Coe I.R., and Sweeney G. Leptin increases cardiomyocyte hyperplasia via extracellular signal-regulated kinase- and phosphatidylinositol 3-kinase-dependent signaling pathways. Endocrinology 145 (2004) 1550-1555
39. Wang Z., Zhou Y.T., Kakuma T., Lee Y., Kalra S.P., Kalra P.S., Pan W., and Unger R.H. Leptin resistance of adipocytes in obesity: role of suppressors of cytokine signaling. Biochem. Biophys. Res. Commun. 277 (2000) 20-26
40. Wang L.G., Beklemisheva A., Liu X.M., Ferrari A.C., Feng J., and Chiao J.W. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Mol. Carcinog. 46 1 (2006) 24-31
41. Wormald S., and Hilton D.J. Inhibitors of cytokine signal transduction. J. Biol. Chem. 279 (2004) 821-824
42. Yu C.R., Mahdi R.M., Ebong S., Vistica B.P., Gery I., and Egwuagu C.E. Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells. J. Biol. Chem. 278 (2003) 29752-29759